- Home
- TSBK vs ABEO Comparison
TSBK vs ABEO Comparison
Compare TSBK & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSBK
- ABEO
- Stock Information
- Founded
- TSBK 1915
- ABEO 1974
- Country
- TSBK United States
- ABEO United States
- Employees
- TSBK N/A
- ABEO N/A
- Industry
- TSBK Banks
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- TSBK Finance
- ABEO Health Care
- Exchange
- TSBK Nasdaq
- ABEO Nasdaq
- Market Cap
- TSBK 248.8M
- ABEO 256.9M
- IPO Year
- TSBK 1998
- ABEO 1980
- Fundamental
- Price
- TSBK $32.39
- ABEO $6.00
- Analyst Decision
- TSBK
- ABEO Strong Buy
- Analyst Count
- TSBK 0
- ABEO 6
- Target Price
- TSBK N/A
- ABEO $18.00
- AVG Volume (30 Days)
- TSBK 12.3K
- ABEO 1.1M
- Earning Date
- TSBK 07-22-2025
- ABEO 08-11-2025
- Dividend Yield
- TSBK 3.21%
- ABEO N/A
- EPS Growth
- TSBK 6.24
- ABEO N/A
- EPS
- TSBK 3.25
- ABEO N/A
- Revenue
- TSBK $76,813,000.00
- ABEO N/A
- Revenue This Year
- TSBK N/A
- ABEO N/A
- Revenue Next Year
- TSBK N/A
- ABEO $323.51
- P/E Ratio
- TSBK $9.97
- ABEO N/A
- Revenue Growth
- TSBK 2.71
- ABEO N/A
- 52 Week Low
- TSBK $24.81
- ABEO $3.93
- 52 Week High
- TSBK $33.98
- ABEO $7.32
- Technical
- Relative Strength Index (RSI)
- TSBK 56.09
- ABEO 48.03
- Support Level
- TSBK $31.66
- ABEO $5.49
- Resistance Level
- TSBK $32.25
- ABEO $6.11
- Average True Range (ATR)
- TSBK 0.69
- ABEO 0.28
- MACD
- TSBK 0.12
- ABEO -0.04
- Stochastic Oscillator
- TSBK 75.98
- ABEO 47.06
About TSBK Timberland Bancorp Inc.
Timberland Bancorp Inc is a bank holding company. It has one reportable operating segment which is defined as community banking in western Washington under the operating name Timberland Bank. The bank offers a variety of services such as checking accounts, online and mobile banking, savings accounts, home loans, consumer loans, construction loans, business rewards, cash management, small business solutions, and business checking accounts among others. It also offers loans to real estate, including residential and commercial, multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans, and land loans.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.